BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27712037)

  • 1. In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice.
    Li H; Clarke JD; Dzierlenga AL; Bear J; Goedken MJ; Cherrington NJ
    J Biochem Mol Toxicol; 2017 Feb; 31(2):. PubMed ID: 27712037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis.
    Li H; Canet MJ; Clarke JD; Billheimer D; Xanthakos SA; Lavine JE; Erickson RP; Cherrington NJ
    Drug Metab Dispos; 2017 Dec; 45(12):1317-1325. PubMed ID: 28986475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of nonalcoholic fatty liver disease-induced drug metabolism by comparative global toxicoproteomics.
    Na AY; Jo JJ; Kwon OK; Shrestha R; Cho PJ; Kim KM; Ki SH; Lee TH; Jeon TW; Jeong TC; Lee S
    Toxicol Appl Pharmacol; 2018 Aug; 352():28-37. PubMed ID: 29792946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Nonalcoholic Fatty Liver Disease on Hepatic CYP2B1 and in Vivo Bupropion Disposition in Rats Fed a High-Fat or Methionine/Choline-Deficient Diet.
    Cho SJ; Kim SB; Cho HJ; Chong S; Chung SJ; Kang IM; Lee JI; Yoon IS; Kim DD
    J Agric Food Chem; 2016 Jul; 64(27):5598-606. PubMed ID: 27321734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis.
    Wells MA; Vendrov KC; Edin ML; Ferslew BC; Zha W; Nguyen BK; Church RJ; Lih FB; DeGraff LM; Brouwer KL; Barritt AS; Zeldin DC; Lee CR
    Prostaglandins Other Lipid Mediat; 2016 Sep; 125():19-29. PubMed ID: 27401401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diet-induced non-alcoholic fatty liver disease affects expression of major cytochrome P450 genes in a mouse model.
    Chiba T; Noji K; Shinozaki S; Suzuki S; Umegaki K; Shimokado K
    J Pharm Pharmacol; 2016 Dec; 68(12):1567-1576. PubMed ID: 27757967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of High-fat and High-cholesterol Diet on Major CYP Activities in the Liver].
    Suzuki S; Sato Y; Umegaki K; Chiba T
    Yakugaku Zasshi; 2016; 136(9):1297-305. PubMed ID: 27592832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model.
    Tzeng TF; Tzeng YC; Cheng YJ; Liou SS; Liu IM
    Nutrients; 2015 Oct; 7(10):8670-84. PubMed ID: 26506376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coleus forskohlii Extract Attenuated the Beneficial Effect of Diet-Treatment on NASH in Mouse Model.
    Suzuki S; Nishijima C; Sato Y; Umegaki K; Murata M; Chiba T
    J Nutr Sci Vitaminol (Tokyo); 2020; 66(2):191-199. PubMed ID: 32350181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoprotective and antioxidant activities of extracts from Salvia-Nelumbinis naturalis against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet in mice.
    Liu Y; Song H; Wang L; Xu H; Shu X; Zhang L; Li Y; Li D; Ji G
    J Transl Med; 2014 Nov; 12():315. PubMed ID: 25406833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis.
    Canet MJ; Hardwick RN; Lake AD; Dzierlenga AL; Clarke JD; Goedken MJ; Cherrington NJ
    Drug Metab Dispos; 2015 Feb; 43(2):266-72. PubMed ID: 25488932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model.
    Machado MV; Kruger L; Jewell ML; Michelotti GA; Pereira Tde A; Xie G; Moylan CA; Diehl AM
    Dig Dis Sci; 2016 Jan; 61(1):137-48. PubMed ID: 26403427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of cytochrome P450 in nonalcoholic fatty liver induced by high-fat diet: a gene expression profile analysis].
    Liu Y; Cheng F; Luo YX; Hu P; Ren H; Peng ML
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):285-290. PubMed ID: 28494548
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.
    Weltman MD; Farrell GC; Hall P; Ingelman-Sundberg M; Liddle C
    Hepatology; 1998 Jan; 27(1):128-33. PubMed ID: 9425928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hepatic cytochrome P450 in a mouse model of ulcerative colitis changes with pathological conditions.
    Kusunoki Y; Ikarashi N; Matsuda S; Matsukawa Y; Kitaoka S; Kon R; Tajima M; Wakui N; Ochiai W; Machida Y; Sugiyama K
    J Gastroenterol Hepatol; 2015 Nov; 30(11):1618-26. PubMed ID: 25867644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis.
    Yoshimine Y; Uto H; Kumagai K; Mawatari S; Arima S; Ibusuki R; Mera K; Nosaki T; Kanmura S; Numata M; Tamai T; Moriuchi A; Tsubouchi H; Ido A
    Oncol Rep; 2015 Apr; 33(4):1657-66. PubMed ID: 25607821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exendin‑4, a glucagon‑like peptide‑1 receptor agonist, modulates hepatic fatty acid composition and Δ‑5‑desaturase index in a murine model of non‑alcoholic steatohepatitis.
    Kawaguchi T; Itou M; Taniguchi E; Sata M
    Int J Mol Med; 2014 Sep; 34(3):782-7. PubMed ID: 24993337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular matrix and cytochrome P450 gene expression can distinguish steatohepatitis from steatosis in mice.
    Hennig EE; Mikula M; Goryca K; Paziewska A; Ledwon J; Nesteruk M; Woszczynski M; Walewska-Zielecka B; Pysniak K; Ostrowski J
    J Cell Mol Med; 2014 Sep; 18(9):1762-72. PubMed ID: 24913135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting-Induced Changes in Hepatic P450 Mediated Drug Metabolism Are Largely Independent of the Constitutive Androstane Receptor CAR.
    de Vries EM; Lammers LA; Achterbergh R; Klümpen HJ; Mathot RA; Boelen A; Romijn JA
    PLoS One; 2016; 11(7):e0159552. PubMed ID: 27434302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.
    Leclercq IA; Farrell GC; Field J; Bell DR; Gonzalez FJ; Robertson GR
    J Clin Invest; 2000 Apr; 105(8):1067-75. PubMed ID: 10772651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.